Treatment resistant depression: methodological overview and operational criteria (Q33542571)

27 July 2017

1 reference

title

Treatment resistant depression: methodological overview and operational criteria (English)

1 reference

27 July 2017

Souery D

1

1 reference

27 July 2017

Amsterdam J

2

1 reference

27 July 2017

de Montigny C

3

1 reference

27 July 2017

Lecrubier Y

4

1 reference

27 July 2017

Montgomery S

5

1 reference

27 July 2017

Lipp O

6

1 reference

27 July 2017

Racagni G

7

1 reference

27 July 2017

Zohar J

8

1 reference

27 July 2017

Mendlewicz J

9

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

European Neuropsychopharmacology

27 July 2017

1 reference

27 July 2017

9

1 reference

27 July 2017

1-2

1 reference

27 July 2017

83-91

1 reference

Treatment algorithms in treatment-resistant depression

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Social adjustment of remitted bipolar and unipolar out-patients. A comparison with age- and sex-matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

The importance of Axis II in patients with major depression. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Definition and differential diagnosis of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Efficacy of fluvoxamine in treatment-refractory depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Relationship of patient background characteristics to efficacy of pharmacotherapy in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Viqualine in resistant depression: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Antidepressant plasma levels revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

The clinical meaning of refractory depression: a review for the clinician

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

A study of the use of antidepressant medication in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Treatment received by depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Antidepressant specificity in atypical depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Does melancholia predict response in major depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Self-esteem in recovered bipolar and unipolar out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Clinical response to amitriptyline among depressed women.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

The importance of dosage in prescribing antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Epidemiology, demography and definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Can we predict the persistence of depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Comorbidity of personality disorders and depression: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

Recent developments in the pharmacotherapy of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900004-2

7 January 2021

10.1016/S0924-977X(98)00004-2

Identifiers

DOI

1 reference

27 July 2017

1 reference